Publication update – National SACT Breast regimen specific consent forms

New consent forms for breast cancer have been added to the CRUK website at www.cruk.org/sact_consent. Some existing forms have been updated as well.

The new regimens include:

  1. Alpelisib
  2. Olaparib
  3. Pembrolizumab – Carboplatin – Paclitaxel – EC
  4. Pembrolizumab and Paclitaxel
  5. Pembrolizumab and Paclitaxel Albumin-Bound
  6. Sacituzumab Govitecan

Regimens that have been updated include:

  1. Capecitabine
  2. Neratinib
  3. Palbociclib
  4. Ribociclib
  5. Trastuzumab
  6. Vinorelbine
  7. Vinorelbine and Capecitabine

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

Any questions, please do let me know.

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Guy’s and St Thomas’ NHS Foundation Trust

Latest News

By SHBN on 8th April 2026

SHBN Webinar – Safer Handling of Hazardous Medicinal Products: Evidence, Practice and Policy Change

This session will bring together research and policy perspectives to explore the current evidence base, the practical realities faced by healthcare professionals, and the policy considerations shaping future improvements in…

Read article
By BOPA Pharmacy Technician Subcommittee on 7th April 2026

Sharing Best Practice of BOPA Member Sarah Goman (Senior Pharmacy Technician) – New Pharmacy Patient Information Animations Launched at Velindre University NHS Trust

New Pharmacy Patient Information Animations Launched! – Velindre University NHS Trust Sarah Goman, Pharmacy Patient Education Team Lead and the driving force behind these videos, said: “We wanted to make…

Read article
By Caoimhe Keenan on 7th April 2026

APTUK joins BOPA and PASG in Pharmacy Workforce Position Statement on Safer Handling of Hazardous SACT Drugs

Dear colleagues, We are pleased to announce that the Association of Pharmacy Technicians UK (APTUK) has now formally joined the British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) in endorsing the…

Read article
By BOPA Committee on 7th April 2026

Launch of the BOPA Initial Training Programme for Cancer Care – Clinical Pharmacy

Dear BOPA Members, We are pleased to announce the launch of the BOPA Initial Training Programme for Cancer Care – Clinical Pharmacy. This programme has been developed to support the standardisation…

Read article